undamentalytics Newsletter
Sign in

Brookdale Senior Living Inc. (BKD) stock

Add to watchlist

Add holding +

NYSE: BKD NYSE Health Care Facilities Next results ~November 6, 2026

D Fundamentals grade

Brookdale Senior Living Inc. is a US-listed company in the health care facilities industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Brookdale Senior Living Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: free cash flow after stock pay is not positive. We'll show the comparison once resolved.

Brookdale Senior Living Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds155 adding, 134 cuttingOf 66 active managers that changed their stake, 39 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Brookdale Senior Living files

Where Brookdale Senior Living stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.05bn, down 4.4% on a year earlier, a steeper fall than the 0.4% decline a quarter earlier. That puts it 9 of 9 for growth among the health care facilities companies we cover. Free-cash-flow margin held at 0.8%. The diluted share count is up 3.7% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 1 of our 4 financial-health checks.

Our model value for Brookdale Senior Living is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 10, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 6, 2026 (estimated)

Brookdale Senior Living Inc.'s trailing-twelve-month revenue fell 4.4% year on year, with a free-cash-flow margin of 0.8%. Where it stands out: days sales outstanding of 7 days ranks 1 of 12 health care facilities companies we cover. Where it lags: revenue growth of -4.4% ranks 13 of 13 health care facilities companies we cover.

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 47% in the quarter to 2026-06-30, the 3rd beat in the last four quarters.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 9.1% over 90 days.

Things to watch

  • Revenue shrinking. Revenue fell 4.4% over the last 12 months.
  • Share dilution. Diluted shares rose 3.7% in a year.
  • Growth easing. The growth rate is 4.1 points lower than a quarter earlier.
  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 71.2% ranks 13 of 13 health care facilities companies we cover (median 37.7%).
  • Below peers: change in growth rate. Change in growth rate of -4.1pp ranks 12 of 13 health care facilities companies we cover (median -1.4pp).
  • Heavily shorted. 19.2% of the shares available to trade are sold short (8.3 days of average volume to cover).

Latest results: FY2026 Q2

Filed August 10, 2026
Earnings per share
-$0.02 against an average estimate of -$0.04: beat by 47.0%
Revenue
$719m, down 11.6% on a year earlier
Share reaction
-6.0% in the first session after the results on October 8, 2026, against +0.2% for the S&P 500
Next report
November 6, 2026; average EPS estimate -$0.02

Brookdale Senior Living's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.5%
  • 1 week+7.0%
  • 1 month-3.9%
  • This year-3.2%
  • 1 year+12.6%
  • 5 years+57.5%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.1B
Operating margin
3.5%
Net margin
-4.5%
EPS (TTM, diluted)
$-0.58

Growth

Revenue growth
−4.4%
Change in growth rate
−4.1 pts
Share count change
+3.7%

Cash

Free cash flow (TTM)
$23.7M
FCF margin
0.8%
Stock pay % of revenue
0.4%

Earnings

Last results
October 8, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Results
  3. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Brookdale Senior Living Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: free cash flow after stock pay is not positive.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Brookdale Senior Living Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.71 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: This model is withheld pending its input or assumption review.
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$1.3 ~$8.0–$24 Left out: out of range vs price (0.12x)
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Brookdale Senior Living Inc. with Health Care Facilities in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$18.46$12.42$9.70$6.70$7.27$4.43$5.16$2.73$5.82$5.03$10.79$10.44
Market value$3.4bn$2.3bn$1.8bn$1.3bn$1.4bn$817m$954m$520m$1.3bn$1.1bn$2.5bn$2.5bn
+ Net debt (− = net cash)$6.0bn$5.8bn$4.9bn$3.2bn$3.3bn$3.5bn$3.5bn$3.5bn$3.4bn$3.8bn$4.1bn$3.9bn
Enterprise value$9.4bn$8.1bn$6.7bn$4.5bn$4.7bn$4.4bn$4.4bn$4.0bn$4.8bn$4.9bn$6.6bn$6.4bn
Multiples
Price / sales 0.7x0.5x0.4x0.3x0.3x0.2x0.3x0.2x0.4x0.4x0.8x0.8x
Price / earnings —————10.0x——————
Price / free cash flow —57.6x11.0x——41.3x————153.7x105.3x
EV / EBITDA 16.5x16.3x29.9x—13.8x16.3x34.8x12.8x12.9x11.9x17.2x14.9x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

33 /100

Weak moat

How hard Brookdale Senior Living's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -3.1% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 24.2%, moving by 2.9 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -0.8%; its worst year was -19.2%.

  • Cash conversion 5 / 20

    Free cash flow was positive in 5 of 10 years, at a median -0.5% of revenue.

  • Discipline 10 / 20

    The diluted share count rose 29.5% over five years; stock-based pay has been a median 0.6% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 6, 2026, before the open. Analysts expect revenue of $717m and EPS of −$0.02 (range −$0.02 to −$0.02) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.62 +17% $2.9bn −9%
Next $0.12 +119% $3.0bn +3%

Next year's EPS estimate has moved +9.1% in 90 days, across 1 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +13.2% on 90 days ago. In the last 30 days, 1 analyst raised Brookdale Senior Living Inc.'s forecast and 0 cut it.

Consensus EPS forecast Brookdale Senior Living Inc., last 90 days
−$1.00 −$0.50 $0.00 $0.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.55 Current fiscal year, 60 days ago: −$0.61 Current fiscal year, 30 days ago: −$0.56 Current fiscal year, 7 days ago: −$0.56 Current fiscal year, Now: −$0.62 −$0.62 Next fiscal year, 90 days ago: $0.11 Next fiscal year, 60 days ago: $0.20 Next fiscal year, 30 days ago: $0.19 Next fiscal year, 7 days ago: $0.17 Next fiscal year, Now: $0.12 $0.12

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.55$0.11
60 days ago −$0.61$0.20
30 days ago −$0.56$0.19
7 days ago −$0.56$0.17
Now −$0.62$0.12

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.04 −$0.02 +47.0%
Mar 2026 −$0.09 −$0.02 +77.2%
Dec 2025 −$0.17 −$0.14 +17.5%
Sept 2025 −$0.18 −$0.20 −6.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 8, 2026

No numeric guidance in Brookdale Senior Living Inc.'s latest earnings release (filed October 8, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

6 analysts, Nov 2026
Buy6100%
Hold00%
Sell00%

Monthly trend

  1. Nov 2026246
  2. Oct 2026246
  3. Sep 2026246

Counts of recommendations published by analysts covering Brookdale Senior Living Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
19.3%
of tradable shares
Days to cover
8.27
at average volume
Short interest, 1 month
+1%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
2.0%
of shares
Employees
22,440
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +12.6%

$9.27 on October 31, 2025 to $10.44

ThenNowEffect
Revenue (last 12 months) $3.2bn $3.1bn −4.4%
P/S multiple 0.7x 0.8x +22.2%
Share count 231m 239m −3.6%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years +152.2%

$4.14 on November 3, 2023 to $10.44

ThenNowEffect
Revenue (last 12 months) $3.0bn $3.1bn +3.0%
P/S multiple 0.3x 0.8x +179.3%
Share count 210m 239m −12.3%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
BKD+17%−47%+113%−14%+115%−3%
Industry peers (median)+21%−6%+9%+17%+30%+13%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
BKD58%42%58%42%67%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
BKD−46%−64%−32%−38%−18%−43%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 93% from November 17, 2015 to March 18, 2020. Getting back needed a 1247% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$9.11 – $16.77
From 52-week high
−37.7%
vs 50-day average
−5.4%
vs 200-day average
−21.6%
Volatility (1 year)
39%
Beta vs S&P 500
0.29

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±6.8%
After a week
7 up, 5 down
typical move ±9.2%
After a month
5 up, 6 down
typical move ±15.1%
Results releasedNext dayS&P 500 next day5 days21 days
October 8, 2026 −6.0% +0.2% −6.3% —
August 10, 2026 −11.7% −0.3% −14.0% −14.6%
July 9, 2026 −4.0% +1.3% +1.8% −5.3%
May 6, 2026 −3.3% +1.1% −8.3% −12.0%
April 8, 2026 +0.1% +3.1% +2.3% −1.4%
February 18, 2026 −10.2% +0.2% −9.1% −15.0%
January 28, 2026 +12.2% −0.2% +15.3% +18.4%
January 12, 2026 +1.7% 0.0% +9.9% +52.3%
November 6, 2025 +1.7% −1.0% +11.5% +15.3%
October 8, 2025 +9.8% +0.3% +8.9% +12.6%
August 6, 2025 −9.5% +0.7% −6.2% −2.4%
July 8, 2025 +11.2% +0.5% +16.6% +16.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Brookdale Senior Living Inc. in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Brookdale Senior Living Inc.
$2.9B $3B $3.1B $3.2B $3.3B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $3B Revenue (TTM), FY23 Q4: $3B Revenue (TTM), FY24 Q1: $3B Revenue (TTM), FY24 Q2: $3.1B Revenue (TTM), FY24 Q3: $3.1B Revenue (TTM), FY24 Q4: $3.1B Revenue (TTM), FY25 Q1: $3.2B Revenue (TTM), FY25 Q2: $3.2B Revenue (TTM), FY25 Q3: $3.2B Revenue (TTM), FY25 Q4: $3.2B Revenue (TTM), FY26 Q1: $3.1B Revenue (TTM), FY26 Q2: $3.1B $3.1B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $3B
FY23 Q4 $3B
FY24 Q1 $3B
FY24 Q2 $3.1B
FY24 Q3 $3.1B
FY24 Q4 $3.1B
FY25 Q1 $3.2B
FY25 Q2 $3.2B
FY25 Q3 $3.2B
FY25 Q4 $3.2B
FY26 Q1 $3.1B
FY26 Q2 $3.1B
Revenue growth, TTM YoY Brookdale Senior Living Inc.
-5% 0% 5% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 7.0% Revenue growth, TTM YoY, FY23 Q4: 6.7% Revenue growth, TTM YoY, FY24 Q1: 5.0% Revenue growth, TTM YoY, FY24 Q2: 3.7% Revenue growth, TTM YoY, FY24 Q3: 4.6% Revenue growth, TTM YoY, FY24 Q4: 3.6% Revenue growth, TTM YoY, FY25 Q1: 3.6% Revenue growth, TTM YoY, FY25 Q2: 3.9% Revenue growth, TTM YoY, FY25 Q3: 3.9% Revenue growth, TTM YoY, FY25 Q4: 2.2% Revenue growth, TTM YoY, FY26 Q1: -0.4% Revenue growth, TTM YoY, FY26 Q2: -4.4% -4.4%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 7.0%
FY23 Q4 6.7%
FY24 Q1 5.0%
FY24 Q2 3.7%
FY24 Q3 4.6%
FY24 Q4 3.6%
FY25 Q1 3.6%
FY25 Q2 3.9%
FY25 Q3 3.9%
FY25 Q4 2.2%
FY26 Q1 -0.4%
FY26 Q2 -4.4%
Operating margin (TTM) Brookdale Senior Living Inc.
-1% 0% 1% 2% 3% 4% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 2.3% Operating margin (TTM), FY23 Q4: 0.6% Operating margin (TTM), FY24 Q1: 1.0% Operating margin (TTM), FY24 Q2: 0.3% Operating margin (TTM), FY24 Q3: 0.8% Operating margin (TTM), FY24 Q4: 1.5% Operating margin (TTM), FY25 Q1: 1.8% Operating margin (TTM), FY25 Q2: 1.6% Operating margin (TTM), FY25 Q3: -0.4% Operating margin (TTM), FY25 Q4: 0.4% Operating margin (TTM), FY26 Q1: 1.1% Operating margin (TTM), FY26 Q2: 3.5% 3.5%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 2.3%
FY23 Q4 0.6%
FY24 Q1 1.0%
FY24 Q2 0.3%
FY24 Q3 0.8%
FY24 Q4 1.5%
FY25 Q1 1.8%
FY25 Q2 1.6%
FY25 Q3 -0.4%
FY25 Q4 0.4%
FY26 Q1 1.1%
FY26 Q2 3.5%
FCF margin (TTM) Brookdale Senior Living Inc.
-6% -4% -2% 0% 2% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -4.6% FCF margin (TTM), FY23 Q4: -2.3% FCF margin (TTM), FY24 Q1: -3.0% FCF margin (TTM), FY24 Q2: -2.9% FCF margin (TTM), FY24 Q3: -1.9% FCF margin (TTM), FY24 Q4: -1.1% FCF margin (TTM), FY25 Q1: -0.3% FCF margin (TTM), FY25 Q2: 0.5% FCF margin (TTM), FY25 Q3: 1.3% FCF margin (TTM), FY25 Q4: 0.5% FCF margin (TTM), FY26 Q1: 0.3% FCF margin (TTM), FY26 Q2: 0.8% 0.8%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -4.6%
FY23 Q4 -2.3%
FY24 Q1 -3.0%
FY24 Q2 -2.9%
FY24 Q3 -1.9%
FY24 Q4 -1.1%
FY25 Q1 -0.3%
FY25 Q2 0.5%
FY25 Q3 1.3%
FY25 Q4 0.5%
FY26 Q1 0.3%
FY26 Q2 0.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 2,100 2,281 2,456 2,769 2,892 3,832 4,961 4,977 4,747 4,531 4,057 3,540 2,758 2,825 3,016 3,125 3,194 3,051
Gross profit — — — — — — 1,448 1,440 1,254 1,068 877 797 501 594 747 799 838 821
EBITDA 311 367 371 351 417 460 571 499 225 −139 339 268 128 311 369 414 384 429
Operating income 30 66 89 81 131 −85 −165 −31 −270 −594 −44 −98 −217 −43 18 47 13 106
Net income −66 −49 −69 −66 −4 −149 −457 −404 −571 −528 −268 82 −99 −238 −189 −202 −263 −138
Diluted EPS −$0.60 −$0.41 −$0.57 −$0.54 −$0.03 −$1.01 −$2.48 −$2.18 −$3.07 −$2.82 −$1.44 $0.44 −$0.54 −$1.25 −$0.84 −$0.89 −$1.12 −$0.58
Growth (year on year)
Revenue +4.9% +8.6% +7.7% +12.7% +4.5% +32.5% +29.5% +0.3% −4.6% −4.5% −10.5% −12.7% −22.1% +2.4% +6.7% +3.6% +2.2% −4.4%
EBITDA +580.0% +18.0% +0.9% −5.2% +18.7% +10.2% +24.3% −12.7% −54.9% −161.7% — −21.1% −52.2% +143.2% +18.5% +12.3% −7.3% +0.7%
Operating income — — +34.5% −8.8% +62.2% −164.7% — — — — — — — — — — — —
Net income — — — — — — — — — — — — −221.1% — — — — —
Diluted EPS — — — — — — — — — — — — −222.7% — — — — —
Margins
Gross margin — — — — — — 29.2% 28.9% 26.4% 23.6% 21.6% 22.5% 18.2% 21.0% 24.8% 25.6% 26.2% 26.9%
EBITDA margin 14.8% 16.1% 15.1% 12.7% 14.4% 12.0% 11.5% 10.0% 4.7% −3.1% 8.4% 7.6% 4.6% 11.0% 12.2% 13.2% 12.0% 14.1%
Operating margin 1.4% 2.9% 3.6% 2.9% 4.5% −2.2% −3.3% −0.6% −5.7% −13.1% −1.1% −2.8% −7.9% −1.5% 0.6% 1.5% 0.4% 3.5%
Net margin −3.2% −2.1% −2.8% −2.4% −0.1% −3.9% −9.2% −8.1% −12.0% −11.7% −6.6% 2.3% −3.6% −8.4% −6.3% −6.5% −8.2% −4.5%
Free-cash-flow margin 5.7% 5.9% 4.4% 3.0% 3.8% −1.6% −2.4% 0.8% 3.5% −0.5% −2.2% 0.6% −9.8% −6.9% −2.3% −1.1% 0.5% 0.8%
Cash flow
Cash from operations 237 228 268 291 366 243 292 374 378 204 216 206 −95 3 163 166 218 224
Capital spending 117 94 160 208 258 304 411 334 214 225 304 186 177 197 233 201 202 200
Free cash flow 120 135 108 83 109 −62 −119 40 164 −22 −88 20 −271 −194 −70 −35 17 24
Stock-based pay 27 21 20 26 26 28 32 32 28 26 23 21 16 14 12 14 12 12
Free cash flow after stock pay 93 114 88 57 83 −90 −150 8 137 −48 −111 −1 −288 −208 −82 −49 5 11
Balance sheet
Cash 66 82 31 69 59 104 88 216 223 398 240 380 347 399 278 309 279 370
Total debt 2,626 2,570 2,399 2,599 2,607 6,146 6,122 6,045 5,142 3,640 3,555 3,916 3,841 3,850 3,726 4,112 4,338 4,273
Net debt (negative = net cash) 2,559 2,488 2,368 2,530 2,548 6,042 6,034 5,829 4,920 3,242 3,315 3,536 3,494 3,451 3,448 3,803 4,059 3,902
Diluted shares 111m 120m 121m 122m 124m 148m 184m 186m 186m 187m 186m 184m 185m 190m 225m 228m 235m 239m
Returned to shareholders
Dividends 0 0 — — — — — — — — — — — — — — — —
Buybacks 0 0 18 0 0 0 0 10 0 4 24 18 0 0 — — — —
Total returned 0 0 18 0 0 0 0 10 0 4 24 18 0 0 — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 4 checks passed · June 30, 2026
What it owns · $5.9bn
Short-term assets $597mLonger-term assets $5.3bn
What it owes, and who funded it · $5.9bn
Short-term liabilities $522mLonger-term liabilities $5.4bnShareholders' equity $-29m
  • Short-term assets cover short-term liabilities $597m of assets due within a year against $522m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $597m short-term assets against $5.4bn of longer-dated liabilities.
  • More cash than debt $370m of cash against $4.3bn of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $224m of operating cash flow against $4.3bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Brookdale Senior Living Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+3.7%
year over year
Days sales outstanding
7 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care facilities
Last 12 months unless stated BKD SGRY ACHC CON PACS ENSG Median
Revenue, last 12 months $3.1bn $3.4bn $3.4bn $2.3bn $5.6bn $5.7bn $3.1bn
Revenue growth, last 12 months −4.4% 4.0% 4.3% 14.0% 15.2% 17.5% 14.0%
Revenue growth, 3-year average 1.0% 8.1% 6.6% — — 16.8% 8.1%
Revenue growth, latest quarter −11.6% 2.7% −0.4% 10.0% 9.1% 14.5% 8.6%
Gross margin 26.9% 23.1% — — — 21.2% 21.2%
Operating margin 3.5% 11.4% 28.7% 16.4% 7.4% 9.0% 9.0%
Operating margin, 3-year average 1.8% 11.5% 23.7% 15.9% 5.2% 8.0% 7.9%
Net margin −4.5% −2.6% −33.4% 8.7% 4.8% 7.0% 4.8%
Cash from operations / revenue 7.3% 7.7% 6.3% 14.7% 10.3% 12.3% 7.7%
Free-cash-flow margin 0.8% 5.6% −4.0% 11.7% 8.2% 10.1% 4.7%
Free-cash-flow margin, 3-year average −0.5% 6.0% −9.5% 10.2% 5.9% 8.1% 5.9%
Stock pay / revenue 0.4% 0.3% 0.9% 0.6% 1.3% 1.1% 0.6%
Change in share count 3.7% 1.3% −1.1% 1.6% −4.5% 1.3% 0.9%

Median of all 13 companies we cover in health care facilities. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

13 health care facilities companies
Measure Company Peer median Rank
Revenue growth Growth -4.4% 14.0% 13 of 13
Change in growth rate Growth -4.1pp -1.4pp 12 of 13
Operating margin Profitability 3.5% 9.0% 7 of 9
Net margin Profitability -4.5% 4.8% 9 of 13
Free-cash-flow margin Cash generation 0.8% 4.7% 8 of 13
Stock pay as % of revenue Cash generation 0.4% 0.6% 4 of 12
Long-term debt as % of assets Balance sheet 71.2% 37.7% 13 of 13
Change in share count Balance sheet 3.7% 0.9% 11 of 13
Days sales outstanding Balance sheet 7 days 48 days 1 of 12

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Health Care Resident Service $3B 95.3% ▲ 2.4%
Reimbursement Costs Managed Communities $141M 4.4% ▼ 1.7%
Management Service $10.9M 0.3% ▲ 3.2%
Other Operating Income $0 0.0% —

From Brookdale Senior Living Inc.'s 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$4.4B
Institutions reporting
291
Shares held vs prior quarter
▲ 6.1%
Positions opened / closed
46 / 39

Top buyers and sellers, Q2 2026: 155 institutions bought and 134 sold ; the biggest buyer was Arrowstreet Capital, Limited Partnership (+3.9M shares) and the biggest seller Flat Footed LLC (−2.4M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $381M 23.6M 8.7% ▲ 4.1%
WCM Investment Management, LLC $229M 14.5M 5.3% ▲ 12.8%
Deerfield Management Company, L.P. $187M 11.6M 4.3% 0.0%
Antipodes Partners Ltd $178M 11.1M 4.1% ▼ 2.8%
Vanguard Portfolio Management LLC $174M 10.8M 4.0% ▲ 4.1%
Vanguard Capital Management LLC $164M 10.2M 3.8% ▲ 0.9%
Carronade Capital Management, LP $159M 9.9M 3.6% ▲ 15.0%
Wellington Management Group LLP $155M 9.6M 3.6% ▲ 9.1%
Maple Rock Capital Partners Inc. $143M 8.9M 3.3% ▲ 9.0%
Geode Capital Management, LLC $112M 7.0M 2.6% ▲ 7.9%
Two Sigma Investments, LP $109M 6.8M 2.5% ▲ 10.4%
Renaissance Technologies LLC $95.8M 6.0M 2.2% ▼ 22.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Brookdale Senior Living Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 6 trades and filings

No trades in Brookdale Senior Living Inc. disclosed in the last 12 months; 6 earlier trades on record.

  • Greg Gianforte(MT):Sale (full), $15,001 - $50,000, traded March 28, 2018, filed April 13, 2018
  • Greg Gianforte(MT):Sale (full), $1,001 - $15,000, traded March 27, 2018, filed April 13, 2018
  • Greg Gianforte(MT):Sale (full), $15,001 - $50,000, traded March 7, 2018, filed March 13, 2018

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

  • October 8, 2026
  • August 10, 2026
  • July 9, 2026
  • May 6, 2026
  • April 8, 2026
  • February 18, 2026

Recent SEC filings

Data status

When each part of this page on Brookdale Senior Living Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Brookdale Senior Living Inc. in brief

What does Brookdale Senior Living Inc. do?
Brookdale Senior Living Inc. is a US-listed company in the health care facilities industry. Its financial year ends in December.
What is Brookdale Senior Living Inc.'s stock ticker?
Brookdale Senior Living Inc. trades under the ticker BKD on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Brookdale Senior Living Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Brookdale Senior Living Inc. reported revenue of $3.1B, 4.4% lower than a year earlier, according to its SEC filings.
What is Brookdale Senior Living Inc.'s free cash flow?
Brookdale Senior Living Inc.'s free-cash-flow margin is 0.8% of revenue over the trailing twelve months, ranking 8 of the 13 health care facilities companies we cover.
Who are Brookdale Senior Living Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., WCM Investment Management, LLC and Deerfield Management Company, L.P. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Brookdale Senior Living Inc.'s market cap?
On November 2, 2026, Brookdale Senior Living Inc.'s market capitalisation was about $2.5B and net debt of $3.9B. Market figures come from third-party market data and may be delayed.
Who are Brookdale Senior Living Inc.'s competitors?
In our Health Care Facilities peer group, the companies closest to Brookdale Senior Living Inc. are Surgery Partners, Inc., Acadia Healthcare Company, Inc., Concentra Group Holdings Parent, Inc., Pacs Group, Inc. and Ensign Group, Inc. The side-by-side comparison below sets their revenue, margins and growth against Brookdale Senior Living Inc.'s.
When is Brookdale Senior Living Inc.'s next earnings date?
Around November 6, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Brookdale Senior Living Inc. announces its own schedule.